Key Documents

View All Documentation

28-3740

Sodium phosphate dibasic dodecahydrate

Name: Sodium phosphate dibasic dodecahydrate
Brand: SAJ

99.0-100.5%, suitable for oxidant determination

Synonym(s):

sec-Sodium phosphate, Disodium hydrogen phosphate dodecahydrate, Disodium phosphate, di-Sodium hydrogen phosphate dodecahydrate

Select a Size

Change View

About This Item

Linear Formula:

Na₂HPO₄ · 12H₂O

CAS Number:

10039-32-4

Molecular Weight:

358.14

UNSPSC Code:

12352300

PubChem Substance ID:

329753174

EC Number:

231-448-7

MDL number:

MFCD00149181

Assay:

99.0-100.5%

Grade:

SAJ special grade

Form:

crystalline

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

grade

SAJ special grade

assay

99.0-100.5%

form

crystalline

availability

available only in Japan

pH

8.4-9.6 (25 °C, 35.8 g/L)

suitability

suitable for oxidant determination

SMILES string

O.O.O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].OP([O-])([O-])=O

InChI

1S/2Na.H3O4P.12H2O/c;;1-5(2,3)4;;;;;;;;;;;;/h;;(H3,1,2,3,4);12*1H2/q2*+1;;;;;;;;;;;;;/p-2

InChI key

DGLRDKLJZLEJCY-UHFFFAOYSA-L

Description

Still not finding the right product?

Explore all of our products under Sodium phosphate dibasic dodecahydrate

Storage Class

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Spectrum of cardiac disease in maternity in a low-resource cohort in South Africa.

Karen Sliwa et al.

Heart (British Cardiac Society), 100(24), 1967-1974 (2014-09-18)

Lack of evidence-based data on the spectrum of cardiovascular disease (CVD) in pregnancy or in the postpartum period, as well as on maternal and fetal outcome, provides challenges for treating physicians, particularly in areas of low resources. The objectives of

Isolated systolic hypertension in young and middle-aged adults and 31-year risk for cardiovascular mortality: the Chicago Heart Association Detection Project in Industry study.

Yuichiro Yano et al.

Journal of the American College of Cardiology, 65(4), 327-335 (2015-01-31)

Isolated systolic hypertension (ISH), defined as systolic blood pressure (SBP) ≥140 mm Hg and diastolic blood pressure (DBP) <90 mm Hg, in younger and middle-aged adults is increasing in prevalence. The aim of this study was to assess the risk

Effect of canagliflozin on blood pressure and adverse events related to osmotic diuresis and reduced intravascular volume in patients with type 2 diabetes mellitus.

Matthew R Weir et al.

Journal of clinical hypertension (Greenwich, Conn.), 16(12), 875-882 (2014-10-21)

The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure (BP) and osmotic diuresis- and intravascular volume reduction-related adverse events (AEs) were evaluated using pooled data from four placebo-controlled, phase 3 studies in patients with type 2

View All Related Papers